Company Search:
Advanced Search
Sponsored Links
Astellas Pharma Incorporated Company Snapshot
Astellas Pharma Incorporated operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Astellas Pharma Incorporated with three other companies in this sector in JAPAN : Daiichi Sankyo Company Limited (2020 sales of 981.79 billion Japanese Yen [US$9.27 billion] of which 93% was Prescription drugs), Eisai Company Limited (695.62 billion Japanese Yen [US$6.57 billion] of which 83% was Pharmaceutical Business), and Shionogi & Co Ltd (333.37 billion Japanese Yen [US$3.15 billion] of which 100% was Prescription Drugs related business).

Sales Analysis. Astellas Pharma Incorporated reported sales of ¥1.30 trillion (US$12.28 billion) for the fiscal year ending March of 2020. This represents a decrease of 0.4% versus 2019, when the company's sales were ¥1.31 trillion. The sales level in 2020 was fairly close to the level five years ago: in 2015, Astellas Pharma Incorporated had sales of ¥1.25 trillion. Contributing to the drop in overall sales was the 52.8% decline in Other Business, from ¥12.26 billion to ¥5.79 billion. There were also decreases in sales in Sales of Pharmaceuticals (down 0.1% to ¥1.26 trillion) . However, these declines were partially offset by the increase in sales of Royalty (up 7.3% to ¥35.76 billion) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Astellas Pharma Incorporated
  Stock Performance Chart for Astellas Pharma Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 1,650.00
(Figures in Japanese Yen )
1 Week -4.3%   13 Weeks -7.1%  
4 Weeks -7.5%   52 Weeks 13.5%  
Astellas Pharma Incorporated Key Data:
  Ticker: 4503 Country: Japan
  Exchanges: PAR TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 1,300,843,000,000
(Year Ending Jan 2021).
Employees: 15,883
  Currency: Japanese Yen Market Cap: 3,064,733,542,200
  Fiscal Yr Ends: March Shares Outstanding: 1,857,414,268
  Share Type: Common Closely Held Shares: 11,225,965
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.